Definium Therapeutics
(NASDAQ) DFTX
Definium Therapeutics Financials at a Glance
Market Cap
$1.80B
Revenue (TTM)
$0.00
Net Income (TTM)
$183.79M
EPS (TTM)
$-2.07
P/E Ratio
-8.75
Dividend
$0.00
Beta (Volatility)
1.58 (High)
Dividend
$0.00
Beta (Volatility)
1.58 (High)
Price
$17.82
Volume
1,329,340
Open
$17.99
Price
$17.82
Volume
1,329,340
Open
$17.99
Previous Close
$17.79
Daily Range
$17.25 - $18.10
52-Week Range
$4.70 - $19.67
Dividend
$0.00
Beta (Volatility)
1.58 (High)
Price
$17.82
Volume
1,329,340
Open
$17.99
Previous Close
$17.79
Daily Range
$17.25 - $18.10
52-Week Range
$4.70 - $19.67
DFTX News
DFTX: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Definium Therapeutics
Industry
Pharmaceuticals
Sector
Health CareEmployees
106
CEO
Robert Barrow, CFA
Website
www.mindmed.coHeadquarters
New York, NY 10007, US
DFTX Financials
Key Financial Metrics (TTM)
Gross Margin
0%
Operating Margin
0%
Net Income Margin
0%
Return on Equity
-64%
Return on Capital
-45%
Return on Assets
-42%
Earnings Yield
-11.43%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$1.80B
Shares Outstanding
99.70M
Volume
1.33M
Short Interest
0.00%
Avg. Volume
1.78M
Financials (TTM)
Gross Profit
$0.00
Operating Income
$166.31M
EBITDA
$178.31M
Operating Cash Flow
$131.56M
Capital Expenditure
$0.00
Free Cash Flow
$131.56M
Cash & ST Invst.
$411.59M
Total Debt
$0.00
Definium Therapeutics Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
$0.00
N/A
Gross Margin
0.00%
N/A
Market Cap
$1.80B
N/A
Market Cap/Employee
$24.39M
N/A
Employees
74
N/A
Net Income
$50.44M
-45.2%
EBITDA
$40.75M
-19.5%
Quarterly Fundamentals
Net Cash
$411.59M
+63.4%
Accounts Receivable
$0.00
N/A
Inventory
$0.00
N/A
Long Term Debt
$0.00
-100.0%
Short Term Debt
$0.00
N/A
Return on Assets
-41.76%
N/A
Return on Invested Capital
-44.54%
N/A
Free Cash Flow
$41.89M
-65.2%
Operating Cash Flow
$41.89M
-65.2%